Wei‐Chung Mao

560 total citations
30 papers, 373 citations indexed

About

Wei‐Chung Mao is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Wei‐Chung Mao has authored 30 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 7 papers in Cognitive Neuroscience. Recurrent topics in Wei‐Chung Mao's work include Bipolar Disorder and Treatment (10 papers), Treatment of Major Depression (7 papers) and Tryptophan and brain disorders (6 papers). Wei‐Chung Mao is often cited by papers focused on Bipolar Disorder and Treatment (10 papers), Treatment of Major Depression (7 papers) and Tryptophan and brain disorders (6 papers). Wei‐Chung Mao collaborates with scholars based in Taiwan, United States and Vietnam. Wei‐Chung Mao's co-authors include Chin‐Bin Yeh, Tien‐Yu Chen, I‐Shin Shiah, Che‐Yi Chao, Hsin‐An Chang, Jia‐Fwu Shyu, Yi‐Jen Hung, Yi-Chyan Chen, Yu-Jung Chen and Susan Shur‐Fen Gau and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Affective Disorders.

In The Last Decade

Wei‐Chung Mao

30 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Chung Mao Taiwan 11 134 94 76 70 65 30 373
Sriram Ramaswamy United States 12 120 0.9× 129 1.4× 51 0.7× 63 0.9× 23 0.4× 33 446
Sang‐Woo Hahn South Korea 15 172 1.3× 148 1.6× 112 1.5× 85 1.2× 91 1.4× 45 589
Amanda K. Ceniti Canada 8 123 0.9× 160 1.7× 59 0.8× 97 1.4× 36 0.6× 13 352
Hee-Ju Kang South Korea 11 75 0.6× 101 1.1× 30 0.4× 65 0.9× 56 0.9× 30 417
Erin L. Reutenauer United States 15 202 1.5× 106 1.1× 91 1.2× 96 1.4× 35 0.5× 16 645
Silvia Fraticelli Italy 10 147 1.1× 240 2.6× 66 0.9× 74 1.1× 103 1.6× 12 534
Cláudia Hara Brazil 12 180 1.3× 59 0.6× 99 1.3× 140 2.0× 60 0.9× 27 481
Yanping Zheng China 8 158 1.2× 181 1.9× 88 1.2× 173 2.5× 42 0.6× 15 539
Alexander Brunnauer Germany 12 181 1.4× 80 0.9× 74 1.0× 98 1.4× 72 1.1× 44 556
Jan Jaracz Poland 13 232 1.7× 94 1.0× 85 1.1× 136 1.9× 41 0.6× 34 550

Countries citing papers authored by Wei‐Chung Mao

Since Specialization
Citations

This map shows the geographic impact of Wei‐Chung Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chung Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chung Mao more than expected).

Fields of papers citing papers by Wei‐Chung Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Chung Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chung Mao. The network helps show where Wei‐Chung Mao may publish in the future.

Co-authorship network of co-authors of Wei‐Chung Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Chung Mao. A scholar is included among the top collaborators of Wei‐Chung Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Chung Mao. Wei‐Chung Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mu‐Hong, Tung‐Ping Su, Li‐Fen Chen, et al.. (2023). Cortical inhibition function is associated with baseline suicidal symptoms and post-ketamine suicidal symptom reduction among patients with treatment-resistant depression and strong suicidal ideation. Journal of Psychiatric Research. 161. 48–53. 5 indexed citations
2.
Su, Tung‐Ping, Cheng‐Ta Li, Wei‐Chen Lin, et al.. (2023). A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation. The International Journal of Neuropsychopharmacology. 26(5). 331–339. 26 indexed citations
3.
Chen, Mu‐Hong, Tung‐Ping Su, Cheng‐Ta Li, et al.. (2023). Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion. European Archives of Psychiatry and Clinical Neuroscience. 274(4). 759–766. 2 indexed citations
4.
Lin, Yen‐Shan, et al.. (2022). Pharmacokinetics and Safety of Sodium Benzoate, a d-Amino Acid Oxidase (DAAO) Inhibitor, in Healthy Subjects: A Phase I, Open-label Study. Clinical Therapeutics. 44(10). 1326–1335. 3 indexed citations
5.
Chen, Mu‐Hong, Cheng‐Ta Li, Wei‐Chen Lin, et al.. (2021). Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials. Journal of Psychiatric Research. 144. 448–454. 5 indexed citations
6.
Chen, Hsi‐Chung, Mong‐Liang Lu, Ming‐Chyi Huang, et al.. (2021). Subgrouping time-dependent prescribing patterns of first-onset major depressive episodes by psychotropics dissection. World Journal of Psychiatry. 11(11). 1116–1128. 1 indexed citations
7.
Chen, Tien‐Yu, John W. Winkelman, Wei‐Chung Mao, et al.. (2020). Real‐world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism. Journal of Thrombosis and Haemostasis. 18(11). 2878–2888. 8 indexed citations
8.
Wang, Hui‐Yi, San‐Yuan Huang, Hui‐Wen Yeh, et al.. (2018). Forensic Evaluations for Offenders With Dementia in Taiwan's Criminal Courts.. PubMed. 46(1). 45–51. 16 indexed citations
9.
Chen, Tien‐Yu, Masoud Kamali, Che‐Sheng Chu, et al.. (2018). Divalproex and its effect on suicide risk in bipolar disorder: A systematic review and meta-analysis of multinational observational studies. Journal of Affective Disorders. 245. 812–818. 14 indexed citations
10.
Chen, Tien‐Yu, John W. Winkelman, Wei‐Chung Mao, et al.. (2017). The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia. CHEST Journal. 153(1). 161–171. 35 indexed citations
11.
Chen, Tien‐Yu, et al.. (2016). Reversible Godot Syndrome in an Elderly Patient With Frontal Lobe Meningioma. The American Journal of the Medical Sciences. 351(2). 215–216. 1 indexed citations
12.
Mao, Wei‐Chung, Tien‐Yu Chen, Yu‐Ching Chou, et al.. (2015). Effects of a selective educational system on fatigue, sleep problems, daytime sleepiness, and depression among senior high school adolescents in Taiwan. Neuropsychiatric Disease and Treatment. 11. 741–741. 43 indexed citations
13.
Chou, Yuan‐Hwa, et al.. (2010). Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disorders. 12(3). 312–318. 29 indexed citations
14.
Mao, Wei‐Chung, et al.. (2009). Mania complicated with delirium following cessation of long-term lithium therapy. General Hospital Psychiatry. 32(1). 102–104. 2 indexed citations
15.
Shiah, I‐Shin, et al.. (2008). Adjunctive Use of Methylphenidate in the Treatment of Psychotic Unipolar Depression. Clinical Neuropharmacology. 31(4). 245–247. 7 indexed citations
16.
Chao, Che‐Yi, et al.. (2008). Relationship of attention‐deficit–hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men. Psychiatry and Clinical Neurosciences. 62(4). 421–426. 50 indexed citations
17.
Shiah, I‐Shin, et al.. (2006). Treatment of paraphilic sexual disorder: the use of topiramate in fetishism. International Clinical Psychopharmacology. 21(4). 241–243. 14 indexed citations
18.
Shiah, I‐Shin, et al.. (2005). Combination Treatment of Clozapine and Topiramate in Resistant Rapid-Cycling Bipolar Disorder. Clinical Neuropharmacology. 28(3). 136–138. 10 indexed citations
19.
Chang, Chuan-Chia, I‐Shin Shiah, Hsin‐An Chang, & Wei‐Chung Mao. (2005). Does domperidone potentiate mirtazapine-associated restless legs syndrome?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(2). 316–318. 14 indexed citations
20.
Shiah, I‐Shin, et al.. (2005). Ziprasidone in the treatment of Parkinson’s disease psychosis. European Psychiatry. 21(8). 578–579. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026